Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Seizures Market from 2024 to 2025?

The market size for seizures has seen robust growth over the past few years. It’s projected to expand from a $3.20 billion value in 2024 to an estimated $4.35 billion in 2025, boasting a compound annual growth rate (CAGR) of 6.2%. Factors contributing to this considerable growth in the past include an increase in instances of epilepsy and seizures, heightened awareness, improving rates of diagnosis, escalated research and development targeted at neurological disorders, increased initiatives by the government and non-profit organizations aimed at raising awareness about epilepsy, and a growing aging population.

What Is the Projected Market Size of the Seizures Market?

The market size for seizures is predicted to witness robust growth in the coming years, expanding to $5.49 billion by 2029 with a compound annual growth rate (CAGR) of 6.0%. This growth for the forecast period is credited to factors such as the growth of the elderly population susceptible to neurological disorders, rise in R&D investments in seizure treatments, escalation in global healthcare spending, increased demand for epilepsy medications, and a surge in instances of seizure disorders. The forecast period is also characterized by prominent trends including technological advances in seizure detection and surveillance tools, breakthroughs affecting drug approvals and reimbursements, developments in genetic studies for precision seizure treatments, the integration of digital health solutions for remote seizure tracking, and progress in epilepsy medicine.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23511&type=smp

Who are the Major Competitors in the Seizures Market Outlook?

Major companies operating in the seizures market are Johnson & Johnson Service Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Viatris Inc., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., UCB S.A., Eisai Co. Ltd., H. Lundbeck A/S, Zydus Lifesciences Limited, SK Biopharmaceuticals Co. Ltd., Neurocrine Biosciences Inc., Supernus Pharmaceuticals Inc., Taro Pharmaceutical Industries Ltd., Marinus Pharmaceuticals Inc., Eton Pharmaceuticals Inc., Sunovion Pharmaceuticals Inc.

What Is Fueling Growth in the Seizures Market?

The escalating rates of traumatic brain injuries are anticipated to fuel the expansion of the seizures market in the future. Traumatic brain injuries, or TBI, refer to any damage to the brain resulting from an unexpected external impact, such as a strike, concussion, or a penetrating wound to the skull. The ever-growing number of road mishaps, due to high-speed impact and diverted driving, are leading to a higher frequency of serious cranial injuries. Seizures can act as an initial signal for traumatic brain injuries, allowing physicians to detect and control the underlying brain damage more proficiently. For example, in October 2023, a report released by the South Dakota Department of Health, a governmental agency in South Dakota, stated that in 2022, South Dakota had the 9th highest age-adjusted rate of TBI-related mortality at 26.4 per 100,000. Moreover, in April 2024, the American Association of Neurological Surgeons, a professional organization based in the US, approximated that between 1.7 and 3.8 million TBIs occur in the US annually. Therefore, the rising incidence of traumatic brain injuries is stimulating the growth of the seizures market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=23511&type=smp

Which Seizures Market Segments Are Growing the Fastest?

The seizures market covered in this report is segmented –

1) By Drug Type: First Generation Anti-Epileptics, Second Generation Anti-Epileptics, Third Generation Anti-Epileptics

2) By Route Of Administration: Oral, Parenteral, Topical

3) By Distribution Channel: Hospitals Pharmacies, Independent Pharmacies, Online Pharmacies

4) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Homecare Settings, Other End-Users

Subsegments:

1) By First Generation Anti-Epileptics: Phenytoin, Carbamazepine, Valproate, Phenobarbital, Primidone, Ethosuximide

2) By Second Generation Anti-Epileptics: Lamotrigine, Levetiracetam, Topiramate, Oxcarbazepine, Zonisamide, Gabapentin, Pregabalin

3) By Third Generation Anti-Epileptics: Lacosamide, Perampanel, Brivaracetam, Eslicarbazepine, Cenobamate

Which Industry Trends Are Shaping the Future of the Seizures Market?

Leading players in the seizures market are working on novel product development such as buccal film to boost patient adherence and provide more accessible treatment options. Buccal film is a slim, soluble strip applied by placing it against the inside of the cheek (or buccal mucosa), allowing the medication to be absorbed directly into the bloodstream. For instance, in December 2024, U.S.-based pharmaceutical company Aquestive Therapeutics Inc. obtained U.S. FDA approval for unique drug exclusivity for Libervant (diazepam) buccal film, designed for two to five-year-old patients with seizure clusters. This ground-breaking formulation presents a non-invasive, simple method of diazepam administration ensuring swift absorption through the buccal mucosa for quicker therapeutic effect. Libervant, being the first and sole orally administered diazepam film approved for this demographic, aims to facilitate caregiver handling and improve patient adherence. This exclusivity further solidifies Aquestive Therapeutics’ stance in propelling oral film-based epilepsy therapies.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/seizures-global-market-report

Which Countries Are Leading the Seizures Market?

North America was the largest region in the seizures market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the seizures market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=23511

This Report Delivers Insight On:

1. How big is the seizures market, and how is it changing globally?

2. Who are the major companies in the seizures market, and how are they performing?

3. What are the key opportunities and risks in the seizures market right now?

4. Which products or customer segments are growing the most in the seizures market?

5. What factors are helping or slowing down the growth of the seizures market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.